Kyoto Pharmaceutical Industries, Ltd.
USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Kyoto ranks #36,174 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 6 technology areas.
- #36,174
- of 49,997 US assignees by volume
- 21st percentile
- by Innovation Score (26.7/100)
- 14.4
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R36174 · Foreign Corporation #36,174 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #36,174/49,997
- PHOTO-FINISH Tokyo Kikai Seisakusho
- CPC-NARROW A61P · 6 areas
- INNOV-THIN 26.7/100
- CLAIMS-RICH 14.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Kabushiki Kaisha Tokyo Kikai Seisakusho (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Kyoto’s 26.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Kyoto
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Advanced Absorbent · near 27
Advanced Absorbent · near
27 score
- Ahram Biosystems · near 27
Ahram Biosystems · near
27 score
- Kyoto Pharmaceutical… · this assignee 27
Kyoto Pharmaceutical… · this assignee
27 score
- LEM Intellectual… · near 27
LEM Intellectual… · near
27 score
- Netseer · near 27
Netseer · near
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Kyoto's Innovation Score is 26.7/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Kyoto?
Each dot is one of Kyoto’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kyoto’s own 14.4 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Kyoto's grants concentrate
Kyoto Pharmaceutical Industries, Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2019. By volume, Kyoto sits between Kuka Systems North America LLC and Kabushiki Kaisha Tokyo Kikai Seisakusho.
Kyoto's three-year grant acceleration
Kyoto Pharmaceutical Industries, Ltd. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Kyoto's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Kuka Systems Nort…
Kuka Systems North America LLC
7 patents
- Kure
Kure, LLC
7 patents
- Kuros Biosciences
Kuros Biosciences AG
7 patents
- Kyocera SOC
Kyocera SOC Corporation
7 patents
- Kyoto Semiconduct…
Kyoto Semiconductor Co., Ltd.
7 patents
- Kyusyu Nanotec Op…
Kyusyu Nanotec Optics Co., Ltd.
7 patents
- Kyynel OY
Kyynel OY
7 patents
- Tokyo Kikai Seisa…
Kabushiki Kaisha Tokyo Kikai Seisakusho
7 patents
- Kyoto Pharmaceuti… ◀
Kyoto Pharmaceutical Industries, Ltd.
7 patents
What this shows Kyoto holds 7 patents at rank #36,114, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Kyoto
By rank, the assignees closest to #36,114 in granted patent volume.
- Kuka Systems North America LLC #36,110 · 7 patents
- Kure, LLC #36,111 · 7 patents
- Kuros Biosciences AG #36,112 · 7 patents
- Kyocera SOC Corporation #36,113 · 7 patents
- Kyoto Semiconductor Co., Ltd. #36,115 · 7 patents
- Kyusyu Nanotec Optics Co., Ltd. #36,116 · 7 patents
- Kyynel OY #36,117 · 7 patents
- Kabushiki Kaisha Tokyo Kikai Seisakusho #36,118 · 7 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Kyoto's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Kyoto, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Kyoto ranks #2,588 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (27 here).
Kyoto's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 21st percentile higher than 21% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 28.6% |
| 2019 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2021 | 1 | 14.3% |
| 2022 | 1 | 14.3% |
| 2025partial year | 1 | 14.3% |
Which technologies does Kyoto Pharmaceutical Industries, Ltd. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Kyoto Pharmaceutical Industries, Ltd.'s patent record in context - here's where to go next.
- Kyoto Pharmaceutical Industries, Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #36,174 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Kyoto Pharmaceutical Industries, Ltd. against Kuka Systems North America LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.